AAVANTI
Dead / Abandoned — Abandoned — failure to respond (as of 01 Jan 2020)
What this means for you
This application is over — abandoned 13 Dec 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88359936
- Mark type
- Stylized text
- Filed
- 27 Mar 2019
- Abandoned
- 13 Dec 2019
- Attorney of record
- Thomas C. McThenia, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Biological treatment for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological drugs for treatment of genetic diseases and Friedreich's Ataxia; biological drugs for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; gene therapy products, namely, therapeutics for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents
Owner
- AAVANTIBIO, INC., GAINESVILLE, FL, US
- Aavanti LLC, Gainesville, FL, US
Prosecution history
- 02 Jan 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Jan 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 02 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Jun 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jun 2019 — NON-FINAL ACTION E-MAILED
- 12 Jun 2019 — NON-FINAL ACTION WRITTEN
- 06 Jun 2019 — ASSIGNED TO EXAMINER
- 15 Apr 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Mar 2019 — NEW APPLICATION ENTERED